Approach to pulmonary hypertension.

被引:0
|
作者
Yung G.L. [1 ]
Rubin L.J. [1 ]
机构
[1] Division of Pulmonary and Critical Care Medicine, University of California, San Diego School of Medicine, La Jolla, CA
关键词
Pulmonary Hypertension; Idiopathic Pulmonary Fibrosis; Epoprostenol; Primary Pulmonary Hypertension; Pulmonary Hypertensive Patient;
D O I
10.1007/s11926-000-0030-x
中图分类号
学科分类号
摘要
Until recently, many physicians considered pulmonary hypertension a rare and esoteric condition that is difficult to diagnose and nearly impossible to treat. However, pulmonary hypertension can complicate a variety of relatively common diseases and, with the development of new and effective therapies, there is a need for greater awareness of this condition. Pulmonary hypertension should be considered when patients present with unexplained shortness of breath, chest pain, or syncope. The usual delay of 1 to 2 years between onset of symptoms and diagnosis underscores the importance of considering pulmonary hypertension in the differential diagnosis of patients who present with atypical cardiorespiratory symptoms.
引用
收藏
页码:517 / 523
页数:6
相关论文
共 50 条
  • [21] Exercise therapy for pulmonary hypertension. A change of paradigm?
    Klein, H.
    Ehlken, N.
    Isele, A.
    Wenz, H.
    Herth, F. J. F.
    Grunig, E.
    PNEUMOLOGE, 2008, 5 (02): : 98 - 102
  • [22] Subcutaneous treprostinil in pediatric pulmonary arterial hypertension.
    Bajolle, F.
    Levy, M.
    Szezepanski, I.
    Bonnet, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [23] Epoprostenol and gas exchange in primary pulmonary hypertension.
    Mazzone, P
    Rafanan, AL
    Lakowski, D
    Hague, K
    Maurer, J
    Mehta, AC
    Schilz, R
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A162 - A162
  • [24] A Novel Role of Nogo in Pulmonary Arterial Hypertension.
    Sutendra, G.
    Bonnet, S.
    Wright, P.
    Dromparis, P.
    Haromy, A.
    Sessa, W. C.
    Michelakis, E. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [25] Bidirectional cavopulmonary connection in patients with pulmonary hypertension.
    Spicer, RL
    Uzark, K
    Lamberti, JJ
    PEDIATRICS, 1998, 102 (03) : 681 - 682
  • [26] The pathogenesis of acute pulmonary edema associated with hypertension.
    Gandhi, SK
    Powers, JC
    Nomeir, A
    Fowle, K
    Kitzman, DW
    Rankin, KM
    Little, WC
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01): : 17 - 22
  • [27] Pulmonary Hypertension. Our Practice in the Intraoperative Management
    Morales-de los Santos, Jose Maria
    Rodriguez-Staff, Felipe
    Manuel Perez-Moreno, Juan
    Yebes, Javier
    Perez, Gonzalo
    Merino, Blanca
    Jimenez, Alicia
    Mar Macias, M.
    Mulero, J. L.
    Carmona, Juan
    LIVER TRANSPLANTATION, 2011, 17 (06) : S251 - S251
  • [28] Orthopnea and pulmonary hypertension. Treat the underlying disease
    Meysman, M.
    Droogmans, S.
    RESPIRATORY MEDICINE CASE REPORTS, 2018, 24 : 105 - 107
  • [29] Circulating CNP-Levels in Pulmonary Hypertension.
    Heinisch, B.
    Skoro-Sajer, N.
    Wolzt, M.
    Lang, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [30] Psychosocial implications of familiar primary pulmonary hypertension.
    Lientz, EA
    Clayton, EW
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 209 - 209